PALO ALTO, CA – Today, United States Senator Edward Markey (D-MA)announced his endorsement of Proposition 14 – the California Stem Cell Research, Treatments and Cures Initiative of 2020. Senator Markey has been a longtime advocate and champion for increased research funding for chronic diseases, conditions and illnesses including stem cell science. Over more than four
For more than 20 years, I was proud to work for you as a Senator and Member of the State Assembly, and later as Chairman of the California Democratic Party. For the past 11 years, I have had the honor of serving as the Vice President of the California Institute for Regenerative Medicine (CIRM), a state
California voters a few years ago agreed to dive into stem cell research in hopes of finding cures and treatments for 75 diseases and conditions afflicting people. Proposition 14 on the Nov. 3 ballot would keep it going. Previous funding created more than 1,000 medical projects at 70 institutions across the state. Research has saved and improved
PALO ALTO, CA – California’s leading elected officials – from our governor and local mayors to our federal and state representatives – are united in support of Proposition 14. The Initiative will continue the state’s investment in advancing new stem cell research, treatments and cures for chronic diseases and conditions such as cancer, Diabetes, heart
What sets California apart is our ability and desire to lead. California’s forward-looking leadership has improved the lives of those who live here – and around the world. The Golden State boasts the 5th largest economy, the biggest and best public university systems and, thanks to support from California voters, it’s the global epicenter for advancing
In 2015, about half of the population in California was living with at least one chronic condition, and the projected cost of care for these devastating diseases is $4.7 trillion by 2030. Whether it is a family member, friend or ourselves, most of us know someone with a chronic disease or condition. With Proposition 14,
California Proposition 14, the Stem Cell Research Institute Bond Initiative, is on the November ballot. A “yes” vote supports issuing $5.5 billion general obligation bonds for the state’s stem cell research institute and making changes to the institute’s governance structure and programs. A “no” vote opposes issuing $5.5 billion general obligation bonds for the state’s
In a recent clinical trial for lymphoma, immune cell therapy completely cleared cancer in 62% of patients —some were on their fifth treatment course. For those patients, the results were a miracle. But it could be so much more. Consider when immune cell therapy is the first treatment. Imagine the lives saved — the patients
Prop. 14: Stem cell research Our vote: Yes This measure would allow California to borrow $5.5 billion to continue funding the California Institute for Regenerative Medicine for stem cell research and other medical research, therapy development, medical training and construction of research facilities. This is important research that can yield positive health care impacts.
